HISUN PHARM HANGZHOU FDA Approval ANDA 206194

ANDA 206194

HISUN PHARM HANGZHOU

FDA Drug Application

Application #206194

Application Sponsors

ANDA 206194HISUN PHARM HANGZHOU

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL75MG0IRBESARTANIRBESARTAN
002TABLET;ORAL150MG0IRBESARTANIRBESARTAN
003TABLET;ORAL300MG0IRBESARTANIRBESARTAN

FDA Submissions

UNKNOWN; ORIG1AP2016-06-14STANDARD
LABELING; LabelingSUPPL2AP2018-11-02STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

HISUN PHARM HANGZHOU
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206194
            [companyName] => HISUN PHARM HANGZHOU
            [docInserts] => ["",""]
            [products] => [{"drugName":"IRBESARTAN","activeIngredients":"IRBESARTAN","strength":"75MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"IRBESARTAN","activeIngredients":"IRBESARTAN","strength":"150MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"IRBESARTAN","activeIngredients":"IRBESARTAN","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/14\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"11\/02\/2018","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2018-11-02
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.